161 related articles for article (PubMed ID: 2498468)
1. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
Casal MJ; Rodriguez FC; Luna MD; Benavente MC
Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
[No Abstract] [Full Text] [Related]
5. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
7. Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
Ruth MM; Sangen JJN; Wertheim HFL; van Ingen J
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652235
[No Abstract] [Full Text] [Related]
8. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Texier-Maugein J; Mormède M; Fourche J; Bébéar C
Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
[TBL] [Abstract][Full Text] [Related]
9. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
Steadham JE; Stall SK; Simmank JL
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Udou T
J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338
[TBL] [Abstract][Full Text] [Related]
12. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.
Casal M; Rodriguez F; Benavente M; Luna M
Eur J Clin Microbiol; 1986 Aug; 5(4):453-4. PubMed ID: 3093225
[No Abstract] [Full Text] [Related]
14. In-vitro susceptibility of mycobacteria to ciprofloxacin.
Collins CH; Uttley AH
J Antimicrob Chemother; 1985 Nov; 16(5):575-80. PubMed ID: 2934361
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
Casal M; Gutierrez J; Ruiz P; Moreno G
Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
[TBL] [Abstract][Full Text] [Related]
16. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Wallace RJ; Swenson JM; Silcox VA; Bullen MG
J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
Casal MJ; Rodriguez FC; Benavente MC
Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactam antibiotics and mycobacteria.
Finch R
J Antimicrob Chemother; 1986 Jul; 18(1):6-8. PubMed ID: 3093446
[No Abstract] [Full Text] [Related]
19. In-vitro activity of quinolones and macrolides against mycobacteria.
Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
[TBL] [Abstract][Full Text] [Related]
20. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
